| Stephanie Shea, MD | |
|
27005 76th Ave, New Hyde Park, NY 11040-1402 | |
| (718) 470-8329 | |
| Not Available |
| Full Name | Stephanie Shea |
|---|---|
| Gender | Female |
| Speciality | Pathology |
| Experience | 8 Years |
| Location | 27005 76th Ave, New Hyde Park, New York |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1376907204 | NPI | - | NPPES |
| Facility Name | Location | Facility Type |
|---|---|---|
| Holy Redeemer Hospital And Medical Center | Meadowbrook, PA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Hr Physician Services | 0042109902 | 143 |
News Archive
The discovery reveals that, when disturbed, this process could contribute to cancer or other diseases by failing to properly control the steps and timing of cell division, the researchers say. The findings are described in the Sept. 23 issue of the Journal of Biological Chemistry, available online now.
The need for long term studies to establish the best means of treating Diabetes, was underlined by Prof John Cleland from the University of Hull at the ESC Congress in Munich. Prof Cleland listed the latest treatment available for patients and voiced his concern about the side-effects and efficacy of available anti-diabetic drugs.
The U.S. Food and Drug Administration approved Xgeva (denosumab) on Thursday to help prevent skeletal-related events (SREs) in patients with cancer that has spread (metastasized) and damaged the bone. Skeletal-related events include bone fractures from cancer and bone pain requiring radiation.
Today's headlines include reports about the policy and political issues currently surrounding the health law's implementation.
The U.S. Food and Drug Administration today approved Octaplas, a pooled plasma (human) blood product for the replacement of clotting proteins (coagulation factors) in certain medical conditions where patients have insufficient levels.
› Verified 2 days ago
| Entity Name | Hr Physician Services |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1881696698 PECOS PAC ID: 0042109902 Enrollment ID: O20040311000028 |
News Archive
The discovery reveals that, when disturbed, this process could contribute to cancer or other diseases by failing to properly control the steps and timing of cell division, the researchers say. The findings are described in the Sept. 23 issue of the Journal of Biological Chemistry, available online now.
The need for long term studies to establish the best means of treating Diabetes, was underlined by Prof John Cleland from the University of Hull at the ESC Congress in Munich. Prof Cleland listed the latest treatment available for patients and voiced his concern about the side-effects and efficacy of available anti-diabetic drugs.
The U.S. Food and Drug Administration approved Xgeva (denosumab) on Thursday to help prevent skeletal-related events (SREs) in patients with cancer that has spread (metastasized) and damaged the bone. Skeletal-related events include bone fractures from cancer and bone pain requiring radiation.
Today's headlines include reports about the policy and political issues currently surrounding the health law's implementation.
The U.S. Food and Drug Administration today approved Octaplas, a pooled plasma (human) blood product for the replacement of clotting proteins (coagulation factors) in certain medical conditions where patients have insufficient levels.
› Verified 2 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Stephanie Shea, MD 3333 Burnet Ave, Cincinnati, OH 45229-3026 Ph: () - | Stephanie Shea, MD 27005 76th Ave, New Hyde Park, NY 11040-1402 Ph: (718) 470-8329 |
News Archive
The discovery reveals that, when disturbed, this process could contribute to cancer or other diseases by failing to properly control the steps and timing of cell division, the researchers say. The findings are described in the Sept. 23 issue of the Journal of Biological Chemistry, available online now.
The need for long term studies to establish the best means of treating Diabetes, was underlined by Prof John Cleland from the University of Hull at the ESC Congress in Munich. Prof Cleland listed the latest treatment available for patients and voiced his concern about the side-effects and efficacy of available anti-diabetic drugs.
The U.S. Food and Drug Administration approved Xgeva (denosumab) on Thursday to help prevent skeletal-related events (SREs) in patients with cancer that has spread (metastasized) and damaged the bone. Skeletal-related events include bone fractures from cancer and bone pain requiring radiation.
Today's headlines include reports about the policy and political issues currently surrounding the health law's implementation.
The U.S. Food and Drug Administration today approved Octaplas, a pooled plasma (human) blood product for the replacement of clotting proteins (coagulation factors) in certain medical conditions where patients have insufficient levels.
› Verified 2 days ago
Dr. Nina Haghi, M.D. Pathology Medicare: Medicare Enrolled Practice Location: 6 Ohio Dr, Suite 202, New Hyde Park, NY 11042 Phone: 516-304-7295 | |
Dr. Mansoor M Nasim, MD, PHD Pathology Medicare: Accepting Medicare Assignments Practice Location: 270-05 76th Ave, B68, New Hyde Park, NY 11040 Phone: 718-470-7490 Fax: 718-347-9171 | |
Andrea Primiani Moy, MD Pathology Medicare: Accepting Medicare Assignments Practice Location: 1991 Marcus Ave Ste 300, New Hyde Park, NY 11042 Phone: 516-719-3376 | |
Peihong Hsu, MD Pathology Medicare: Accepting Medicare Assignments Practice Location: Lijmc-dept Of Laboratory Medicine, 270-05 76th Avenue, New Hyde Park, NY 11040 Phone: 718-470-3091 | |
Ann Anderson, MD Pathology Medicare: Accepting Medicare Assignments Practice Location: Lijmc-dept. Of Pathology, 270-05 76th Avenue, New Hyde Park, NY 11040 Phone: 718-470-3073 | |
Lili Lee, MD Pathology Medicare: Accepting Medicare Assignments Practice Location: 6 Ohio Dr, 202, New Hyde Park, NY 11042 Phone: 516-304-7278 | |
Dr. Sofia Esther Trabulsy, M.D. Pathology Medicare: Accepting Medicare Assignments Practice Location: 2800 Marcus Ave Ste 103, New Hyde Park, NY 11042 Phone: 516-622-6100 |